TIS tissue therapies limited

Ann: Appendix 4C - quarterly , page-4

  1. 492 Posts.
    "Cash expenditure for the next 2 quarters is forecast to be lower than those incurred during the last 2 quarters."

    US trial commencing Jan 2013? 1 mil cash burn next 2 quarters leaves cash on hand at Jan 2013 at ~ 3 mil?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.